Streetbeat News

Products Services

LFLY

UBER

Leafly (NASDAQ:LFLY) CEO Yoko Miyashita discussed the challenges of moving cannabis consumers from unlicensed to legal markets at the Benzinga Cannabis Capital Conference. Leafly recently partnered with Uber (NYSE:UBER) to launch cannabis delivery services in Canada, leveraging existing infrastructures to meet customer demands.

Portfolio Pulse from Javier Hasse

June 22, 2023 | 7:34 pm

QQQ

TQQQ

ProShares UltraPro QQQ (TQQQ) shares are trading higher by 2.26% to $39.73 as new U.S. job market data shows early signs of cooling, aligning with the Federal Reserve's remarks on softer labor market conditions to achieve the 2% inflation target. The Nasdaq-100 Index includes 100 of the largest non-financial companies listed on the Nasdaq Stock Market, many of which are well-known technology companies.

Portfolio Pulse from Henry Khederian

June 22, 2023 | 7:32 pm

DIS

DKNG

EDR

META

TSLA

Elon Musk has challenged Mark Zuckerberg to a cage match, which Zuckerberg has apparently accepted. The potential fight has generated excitement on social media and among sportsbooks. UFC, owned by Endeavor Group Holdings, could potentially host the event, while DraftKings has already shared betting odds.

Portfolio Pulse from Chris Katje

June 22, 2023 | 7:15 pm

AMZN

Amazon announced the launch of its AWS Generative AI Innovation Center, a $100 million program aimed at helping customers build and deploy generative AI solutions. The company's broader AI strategy focuses on delivering AI at scale. Amazon shares rose 3.19% following the announcement.

Portfolio Pulse from Adam Eckert

June 22, 2023 | 7:14 pm

SPCE

OceanGate Expedition's submersible vessel Titan went missing during a Titanic expedition, highlighting the extreme tourism industry. High-priced adventures include space tourism offered by Virgin Galactic Holdings Inc (NYSE:SPCE) and trips to the depths of the Mariana Trench by EYOS Expeditions.

Portfolio Pulse from AJ Fabino

June 22, 2023 | 6:59 pm

LLY

NVO

NVS

TERN

Mizuho initiated coverage on Terns Pharmaceuticals with a Buy rating and a price target of $16, implying a 35% upside. The analyst believes TERN-501 for NASH is the company's most de-risked asset and main driver of valuation. TERN-601 for obesity is considered Terns' hottest asset, while TERN-701 for chronic myeloid leukemia is the most underappreciated.

Portfolio Pulse from Vandana Singh

June 22, 2023 | 6:54 pm

SRPT

The FDA has granted accelerated approval to Sarepta Therapeutics' gene therapy, Elevidys, for Duchenne muscular dystrophy (DMD) in pediatric patients aged 4-5 years with a confirmed mutation in the DMD gene. Continued approval depends on further verification and description of clinical benefit in confirmatory trials. Sarepta is preparing to launch Elevidys and plans to submit a BLA supplement to expand the approved label based on the results of the confirmatory trial.

Portfolio Pulse from Vandana Singh

June 22, 2023 | 6:48 pm

EXAS

Exact Sciences Corporation (NASDAQ:EXAS) is poised to dominate the emerging precision oncology market, with a potential $18 billion market. Analysts reiterate Buy ratings and raise price targets, as the company's Cologuard test shows promising results and management remains confident in future growth prospects.

Portfolio Pulse from Nabaparna Bhattacharya

June 22, 2023 | 6:38 pm

MDB

MongoDB shares are trading higher after the company announced several new product launches, including the MongoDB AI Innovators Program, MongoDB Atlas for Industries, and five new products and features for MongoDB Atlas. A new partnership with Google Cloud was also announced.

Portfolio Pulse from Ryan Gustafson

June 22, 2023 | 6:38 pm

INM

InMed Pharmaceuticals announced that its Phase 2 clinical trial for INM-755 CBN cream, a treatment for symptoms related to epidermolysis bullosa, showed non-statistically significant results for non-wound itch.

Portfolio Pulse from Benzinga Newsdesk

June 22, 2023 | 6:25 pm